Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Death by Light

Abstract:
Nanoparticles as agents for the photodynamic killing of antibiotic-resistant bacteria

Death by Light

Germany | Posted on October 7th, 2009

The increasing antibiotic resistance of bacteria is a serious problem of our time. Hospital germs in particular have developed strains against which practically every current antibiotic is ineffective. In the battle against resistant microbes, a team at the University of Münster (Germany) is now pursuing a new approach involving photodynamic therapy, which is a technique that is already being used in the treatment of certain forms of cancer and macular degeneration. Upon irradiation with light, an agent produces oxygen in a special activated form that is highly toxic to cells. As the researchers led by Cristian A. Strassert and Luisa De Cola report in the journal Angewandte Chemie, they would like to use specially developed nanomaterials that bind specifically to bacterial cells to mark them and kill them under irradiation.

The researchers use nanoparticles made of a special porous material (zeolite L). The particles are modified so they carry a coating of amino groups. These bind preferentially to the surfaces of bacterial cells by means of electrostatic attraction and hydrogen bonds. The researchers put a green fluorescent dye into the channels of the mineral, making the bacteria visible under a fluorescence microscope. The actual "weapons" are photosensitizers anchored on the surface of the nanoparticles. When these molecules are irradiated with light of the right wavelength, they absorb the light energy and transfer it to oxygen molecules found in the surroundings, for example in infected tissue. The oxygen is excited and enters into what is known as the singlet state, in which it is highly reactive and attacks biomolecules - but only in the immediate area in which the singlet oxygen was generated. In this case, the location is right on the bacterial cell where the mineral particle is bound.

The scientists tested their new light-activated killer particles on antibiotic-resistant cultures of E. coli bacteria. After about two hours of irradiation, the bacteria were almost completely killed off. The team achieved comparable results with a strain of resistant gonococci. Furthermore, the researchers from Münster are also considering this material for the treatment of skin cancer. In this case, the tumor cells could be destroyed upon targeted irradiation with red light.

Author: Luisa De Cola, Westfälische Wilhelms-Universität Münster (Germany),
www.uni-muenster.de/Physik.PI/DeCola/ldc.html

Title: Photoactive Hybrid Nanomaterial for Targeting, Labeling, and Killing Antibiotic-Resistant Bacteria

Angewandte Chemie International Edition 2029, 68, No. 42, 7928-7931, doi: 10.1002/anie.200902837

####

For more information, please click here

Contacts:
Editorial office:
or Amy Molnar (US): or Jennifer Beal (UK): or Alina Boey (Asia):

Copyright © Angewandte Chemie

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Possible Futures

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project